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Dendritic cells turn traitorous
 
endritic cells present antigens during immune responses and 
are thought to be important in antitumor activity. However, 
under the influence of the known cancer promoter VEGF-A, 
dendritic cell precursors take on the trappings of endothelial cells 
and contribute to tumor blood vessels, speeding the cancer’s growth, 
according to a report by Jose Conejo-Garcia, Fabian Benencia, 
George Coukos (University of Pennsylvania Medical Center, 
Philadelphia, PA), and colleagues.
Hoping to boost anti-tumor immunity in a mouse model of 
ovarian cancer, Conejo-Garcia et al. found that expression of the 
inflammatory peptides 
 
 
 
-defensins attracted dendritic cells to the 
D
Dendritic precursor cells (brown) contribute to tumor blood vessels.
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Centrosomes take sides
 
he 
 
C. elegans
 
 embryo lacks polarity 
until 
 
 
 
30 min after fertilization. 
Prior evidence implicated the sperm-
donated centrosome, presumably via 
its ability to nucleate microtubules, in 
polarity establishment. Now, Carrie 
Cowan and Anthony Hyman (Max 
Planck Institute, Dresden, Germany) 
find that it is centrosomes themselves 
that are needed. When they ablate 
the centrosome, downstream polarity 
signals such as PAR proteins fail to 
localize as they do in wild-type embryos.
Timing of the centrosome’s ablation 
is crucial. When the team knocks out 
the centrosome before it approaches 
the cortex of the cell, polarity is abol-
ished. However, if the team ablates the 
centrosome after it nears the cortex, 
they induce only slight disruptions in 
the downstream polarity events. Thus, 
the required signal is a transient one.
T
 
tumor. In tumors with low levels of VEGF-A, the immune cells 
slowed the cancer’s growth presumably via anti-tumor immunity, 
but when VEGF-A was abundant, they actually promoted tumor 
growth via increased vascularization. The dendritic cells started 
expressing endothelial cell surface markers and were incorporated 
into the tumor vasculature.
Previous work suggested that this type of dendritic cell conversion 
to an endothelial cell phenotype could occur in vitro, but this is 
the first report of it in vivo. To determine if the observation was 
an artifact of their mouse model or if it occurs in spontaneous 
human cancers, the team examined human tumor samples. 
 
 
 
-defensin is expressed in both ovarian neoplasias and healthy 
postmenopausal ovaries, but occurs at seven times higher levels 
in advanced rather than early stage cancers. Moreover, the team 
found a population of tumor-localized leukocytes that had cell 
surface markers indicative of dendritic cells and endothelial cells, 
similar to those cells in the mouse model. Finally, cancers with 
high levels of VEGF-A and 
 
 
 
-defensins had more vasculature 
than those with lower levels, suggesting that dendritic cells do 
convert to vascular cells in human cancers.
“This is a totally new paradigm for dendritic cell biology,” says 
Coukos. The team has looked primarily at ovarian cancers, but 
Coukos thinks the phenomenon is likely to be common in solid 
tumors. Whether or not there is a healthy reason for dendritic cells 
to participate in vasculogenesis is unclear. 
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That was unexpected. Dogma in the 
field was that it was the centrosome’s 
ability to nucleate microtubules that was 
critical for polarity, as microtubules were 
thought to transport crucial vesicles or 
molecules to the cortex. But microtubule 
nucleation occurs after the critical polar-
ity signal and is now shown not to be 
needed for polarity establishment. “This 
is a real signaling event,” says Cowan. 
“The centrosome appears to be a scaffold 
for some signaling molecule.”
The German group wants to know 
what causes the centrosome to move 
to the cortex and just how close it has 
to get to start PAR localization. One 
idea is that the centrosome signal 
punctures the actin meshwork at the 
cortex and induces cortical flows, but 
the identity of a centrosome-based 
signal that might cause such a break 
remains a mystery.
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Polarization fails when centrosomal compo-
nents are removed (left) but proceeds in the 
absence of microtubule nucleation (right).
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